デフォルト表紙
市場調査レポート
商品コード
1732979

心臓閉鎖装置市場- 世界の産業規模、シェア、動向、機会、予測、閉鎖タイプ別(先天性心欠損閉鎖{手技別(ASD,PDA,VSD)},PFO閉鎖,LAA閉鎖)地域別セグメント、競合、2020-2030年

Heart Closure Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Closure Type (Congenital Heart Defect Closure{By Technique( ASD,PDA,VSD)},PFO Closure, LAA Closure) By Region and Competition, 2020-2030F


出版日
ページ情報
英文 180 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

心臓閉鎖装置市場- 世界の産業規模、シェア、動向、機会、予測、閉鎖タイプ別(先天性心欠損閉鎖{手技別(ASD,PDA,VSD)},PFO閉鎖,LAA閉鎖)地域別セグメント、競合、2020-2030年
出版日: 2025年05月23日
発行: TechSci Research
ページ情報: 英文 180 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心臓閉鎖装置の世界市場は、2024年に28億4,000万米ドルと評価され、予測期間中にCAGR 10.39%で成長し、2030年には51億4,000万米ドルに達すると予測されています。

心臓閉鎖装置は、心房中隔欠損症(ASD)、卵円孔開存症(PFO)、心室中隔欠損症(VSD)などの構造的な心臓の欠陥を治療するために設計されており、開心術に代わる低侵襲の代替医療を提供します。心血管疾患の有病率の上昇、カテーテルを用いた手技の採用の増加、デバイスの材料や設計の進歩、高齢者人口の増加により、市場は急速に拡大しています。経カテーテル的閉鎖装置や強化された画像技術などの技術革新は、これらの手技をより正確かつ低侵襲にし、採用をさらに促進しています。外傷の少ない治療と患者の転帰の改善を求める世界の動きは、特にヘルスケアインフラが発達し、心臓欠陥治療に対する意識が高まっている地域において、これらの装置に対する需要を引き続き促進しています。

市場概要
予測期間 2026-2030
市場規模:2024年 28億4,000万米ドル
市場規模:2030年 51億4,000万米ドル
CAGR:2025年~2030年 10.39%
急成長セグメント CHDクロージャー
最大市場 北米

市場促進要因

技術の進歩

主な市場課題

償還の問題

主要市場動向

経カテーテル閉鎖装置

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の心臓閉鎖装置市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 閉鎖タイプ別(CHD閉鎖、PFO閉鎖、LAA閉鎖)
    • 企業別(2024)
    • 地域別
  • 市場マップ

第6章 北米の心臓閉鎖装置市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米:国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州の心臓閉鎖装置市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州:国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域の心臓閉鎖装置市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域:国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米の心臓閉鎖装置市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの心臓閉鎖装置市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 製品上市
  • 合併と買収

第13章 PESTEL分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Gore & Associates, Inc.
  • Abbott Laboratories
  • AtriCure Inc.
  • Lifetech Scientific
  • Occlutech
  • Lepu Medical Technology(Beijing)Co., Ltd.
  • Heartstitch
  • SMT
  • Cardiac, Inc.
  • Boston Scientific Corporation

第16章 戦略的提言

第17章 調査会社について・免責事項

目次
Product Code: 16279

The Global Heart Closure Devices Market was valued at USD 2.84 billion in 2024 and is projected to reach USD 5.14 billion by 2030, growing at a CAGR of 10.39% during the forecast period. Heart closure devices are designed to treat structural heart defects such as atrial septal defects (ASDs), patent foramen ovale (PFO), and ventricular septal defects (VSD), providing a minimally invasive alternative to open-heart surgery. The market is expanding rapidly due to the rising prevalence of cardiovascular conditions, increasing adoption of catheter-based procedures, advancements in device materials and design, and the growing geriatric population. Technological innovations, such as transcatheter closure devices and enhanced imaging techniques, are making these procedures more precise and less invasive, further driving adoption. The global push for less traumatic interventions and improved patient outcomes continues to fuel demand for these devices, especially in regions with advanced healthcare infrastructure and rising awareness about heart defect treatments.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.84 Billion
Market Size 2030USD 5.14 Billion
CAGR 2025-203010.39%
Fastest Growing SegmentCHD Closure
Largest MarketNorth America

Key Market Drivers

Technological Advancements

Technological progress has significantly contributed to the expansion of the heart closure devices market. Developments in biomaterials and engineering have led to devices that are smaller, more flexible, and easier to implant, improving patient comfort and clinical outcomes. Innovations in catheter-based techniques enable minimally invasive procedures, reducing recovery time and surgical risks. Additionally, the integration of real-time imaging technologies such as 3D imaging and intracardiac echocardiography (ICE) allows for accurate visualization and placement of closure devices. These advancements have expanded treatment options for patients with congenital or acquired heart defects and have made these procedures more accessible and safer, which has helped boost overall market growth.

Key Market Challenges

Reimbursement Issues

Inconsistent and limited reimbursement policies represent a significant challenge in the heart closure devices market. Coverage and reimbursement vary widely across countries and healthcare systems, influencing patient access and the financial viability of procedures. In regions where reimbursement is limited or unclear, patients may face high out-of-pocket costs, deterring them from undergoing treatment. Healthcare providers also encounter administrative burdens and delays in securing reimbursement, which can limit their ability to offer these procedures consistently. These factors create disparities in treatment availability and restrict the adoption of heart closure devices, particularly in lower-income or publicly funded healthcare environments.

Key Market Trends

Transcatheter Closure Devices

Transcatheter closure devices are gaining prominence as the preferred approach for treating structural heart defects. These devices are delivered through catheters, offering a highly targeted and minimally invasive method of closure that reduces surgical complications and shortens recovery time. As precision and ease-of-use improve, these devices are increasingly seen as the standard of care, particularly for conditions like PFO and ASDs. Advanced delivery systems and real-time imaging facilitate accurate deployment, contributing to better procedural outcomes. The growing demand for less invasive cardiac procedures, combined with strong clinical efficacy, is driving widespread adoption of transcatheter closure technologies and accelerating their market penetration.

Key Market Players

  • Gore & Associates, Inc.
  • Abbott Laboratories
  • AtriCure Inc.
  • Lifetech Scientific
  • Occlutech
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Heartstitch
  • SMT
  • Cardiac, Inc.
  • Boston Scientific Corporation

Report Scope

In this report, the Global Heart Closure Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Heart Closure Devices Market, By Closure Type:

  • CHD Closure
  • PFO Closure
  • LAA Closure

Heart Closure Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Heart Closure Devices Market.

Available Customizations

Global Heart Closure Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Heart Closure Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
    • 5.2.2. By Company (2024)
    • 5.2.3. By Region
  • 5.3. Market Map

6. North America Heart Closure Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Heart Closure Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Closure Type
    • 6.3.2. Mexico Heart Closure Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Closure Type
    • 6.3.3. Canada Heart Closure Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Closure Type

7. Europe Heart Closure Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Heart Closure Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Closure Type
    • 7.3.2. Germany Heart Closure Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Closure Type
    • 7.3.3. United Kingdom Heart Closure Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Closure Type
    • 7.3.4. Italy Heart Closure Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Closure Type
    • 7.3.5. Spain Heart Closure Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Closure Type

8. Asia-Pacific Heart Closure Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
    • 8.2.2. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Heart Closure Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Closure Type
    • 8.3.2. India Heart Closure Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Closure Type
    • 8.3.3. South Korea Heart Closure Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Closure Type
    • 8.3.4. Japan Heart Closure Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Closure Type
    • 8.3.5. Australia Heart Closure Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Closure Type

9. South America Heart Closure Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
    • 9.2.2. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Heart Closure Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Closure Type
    • 9.3.2. Argentina Heart Closure Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Closure Type
    • 9.3.3. Colombia Heart Closure Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Closure Type

10. Middle East and Africa Heart Closure Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
    • 10.2.2. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Heart Closure Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Closure Type
    • 10.3.2. Saudi Arabia Heart Closure Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Closure Type
    • 10.3.3. UAE Heart Closure Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Closure Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Gore & Associates, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Abbott Laboratories
  • 15.3. AtriCure Inc.
  • 15.4. Lifetech Scientific
  • 15.5. Occlutech
  • 15.6. Lepu Medical Technology (Beijing) Co., Ltd.
  • 15.7. Heartstitch
  • 15.8. SMT
  • 15.9. Cardiac, Inc.
  • 15.10. Boston Scientific Corporation

16. Strategic Recommendations

17. About Us & Disclaimer